Results for n.j.: 21

NEW YORK, June 12 - A New Jersey bankruptcy court approved the sale of Tropicana Atlantic City Casino and Resort to its pre-bankruptcy lenders, including financier Carl Icahn, for $200 million, Tropicana Entertainment said in...

NEW YORK, June 12 - A New Jersey bankruptcy court approved the sale of Tropicana Atlantic City Casino and Resort to pre-bankruptcy lenders, including financier Carl Icahn, for $200 million, Tropicana Entertainment said in a...

NexMed, Inc. (Nasdaq: NEXM), a developer of innovative products based on the NexACT(R) drug delivery technology, today announced that it has been approved by the State of New Jersey to sell a portion of its...

* Expects US FDA to act on application by mid-2010 * Analysts caution about possible initial drug shortage * Sees N.J. Provenge plant at full capacity in H1 2011 * Shares fall 4.85 percent (Recasts...

* Expects US FDA to act on application by mid-2010 * Expects to double workforce for Provenge launch * Sees N.J. Provenge plant at full capacity in H1 2011 * Shares fall 4.85 percent (Adds...

* Expects US FDA to act on application by mid-2010 * Expects to double workforce for Provenge launch * Sees N.J. Provenge plant at full capacity in H1 2011 * Shares fall 4.7 percent (Adds...

* Expects US FDA to act on application by mid-2010 * Expects to double workforce for Provenge launch * Sees N.J. Provenge plant at full capacity in H1 2011 * Shares down 5 percent (Adds...

PRINCETON, N.J., July 21 - NRG Energy Inc's shareholders rejected the slate of directors Exelon Corp nominated to NRG's board, likely dealing the final blow to Exelon's hostile bid for the independent power producer. The...

NEW BRUNSWICK, N.J., June 4 - Johnson & Johnson told industry analysts on Thursday that it plans to seek approvals by 2010 for new drugs to treat hepatitis C and HIV, and to seek approvals...

* Highlights five therapeutic areas * Wall St counting on pharma to help boost profits NEW BRUNSWICK, N.J., June 4 - Johnson & Johnson detailed new medicines in immunology, neuroscience, cancer and other areas to...